Table 1 of Li, Mol Vis 2009; 15:955-961.
Characteristics |
VKH Patients | |||
---|---|---|---|---|
HLA-DR4+ n=178 (77.4%) |
HLA-DR4– n=52 (22.6%) |
HLA-DRw53+ n=202 (87.9%) |
HLA-DRw5– n=28 (12.1%) |
|
Male | 103 (80.5%) | 25 (19.5%) | 116 (90.6%) | 12 (9.4%) |
Female | 75 (73.5%) | 27 (26.5%) | 86 (84.3%) | 16 (15.7%) |
Neck stiffness | 74 (72.5%) | 28 (27.5%) | 89 (87.3%) | 13 (12.7%) |
Alopecia | 26 (72.2%) | 10 (27.8%) | 30 (83.3%) | 6 (16.7%) |
Poliosis | 65 (73.9%) | 23 (26.1%) | 78 (88.6%) | 10 (11.4%) |
Vitiligo | 41 (74.5%) | 14 (25.5%) | 48 (87.3%) | 7 (12.7%) |
Dysacusia | 57 (69.5%) | 25 (30.5%) | 70 (85.4%) | 12 (14.6%) |
Tinnitus | 61 (84.7%) | 11 (15.3%) | 67 (93.1%) | 5 (6.9%) |
Scalp hypersensitivity | 32 (74.4%) | 11 (25.6%) | 38 (88.4%) | 5 (11.6%) |